Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
LLY

Eli Lilly

$119.20

2.46 (2.11%)

, ZYME

Zymeworks

$16.12

-0.11 (-0.68%)

17:02
01/17/19
01/17
17:02
01/17/19
17:02
Hot Stocks
Zymeworks reports second IND submission milestone in Eli Lilly collaboration »

Zymework (ZYME) reported…

LLY

Eli Lilly

$119.20

2.46 (2.11%)

ZYME

Zymeworks

$16.12

-0.11 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 18

    May

ZYME

Zymeworks

$13.30

1.6 (13.68%)

12:00
12/28/18
12/28
12:00
12/28/18
12:00
Hot Stocks
Zymeworks rises 13.7% »

Zymeworks is up 13.7%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYME

Zymeworks

$15.00

0.085 (0.57%)

04:55
12/14/18
12/14
04:55
12/14/18
04:55
Conference/Events
Zymeworks management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ZYME

Zymeworks

$15.00

0.085 (0.57%)

16:33
12/13/18
12/13
16:33
12/13/18
16:33
Syndicate
Breaking Syndicate news story on Zymeworks »

Zymeworks files $250M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ZYME

Zymeworks

$15.20

0.79 (5.48%)

11:58
12/12/18
12/12
11:58
12/12/18
11:58
Conference/Events
Zymeworks management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ZYME

Zymeworks

$13.15

(0.00%)

12:57
12/08/18
12/08
12:57
12/08/18
12:57
Hot Stocks
Zymeworks submits IND application for ZW49, presents IND-enabling studies »

Zymeworks presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYME

Zymeworks

$11.97

0.46 (4.00%)

, BGNE

BeiGene

$145.71

3.47 (2.44%)

07:28
11/28/18
11/28
07:28
11/28/18
07:28
Recommendations
Zymeworks, BeiGene analyst commentary at Canaccord »

Zymeworks partnership…

ZYME

Zymeworks

$11.97

0.46 (4.00%)

BGNE

BeiGene

$145.71

3.47 (2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 01

    Dec

  • 03

    Dec

ZYME

Zymeworks

$13.56

2.05 (17.81%)

10:00
11/27/18
11/27
10:00
11/27/18
10:00
Hot Stocks
Zymeworks rises 17.5% »

Zymeworks is up 17.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYME

Zymeworks

$11.51

-0.09 (-0.78%)

, BGNE

BeiGene

$142.24

6.03 (4.43%)

06:33
11/27/18
11/27
06:33
11/27/18
06:33
Hot Stocks
Zymeworks, BeiGene announce license and collaboration agreement »

Zymeworks (ZYME) and…

ZYME

Zymeworks

$11.51

-0.09 (-0.78%)

BGNE

BeiGene

$142.24

6.03 (4.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

  • 03

    Dec

Over a quarter ago
CRL

Charles River

$130.56

1.96 (1.52%)

, CRVS

Corvus Pharmaceuticals

$6.91

0.11 (1.62%)

04:55
11/16/18
11/16
04:55
11/16/18
04:55
Conference/Events
European Organization for Research & Treatment of Cancer to hold symposium »

The European Organization…

CRL

Charles River

$130.56

1.96 (1.52%)

CRVS

Corvus Pharmaceuticals

$6.91

0.11 (1.62%)

XCUR

Exicure

$0.00

(0.00%)

ZYME

Zymeworks

$12.82

0.075 (0.59%)

ARWR

Arrowhead

$12.97

0.92 (7.63%)

ALRN

Aileron Therapeutics

$2.24

0.135 (6.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.